Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 603.40
-27.40 (-4.34%)
At close: Nov 6, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 64.16 billion as of November 6, 2026. It is the 12,225th most valuable company in the world and the 748th biggest in India. Its market cap has increased by 294.73% in one year.
Market Cap
64.16B
Enterprise Value
62.88B
Revenue
10.05B
Global Rank
Country Rank
#748 India
PE Ratio
47.81
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 64.16B, an increase of 638,182.89%. That is a compound annual growth rate of 42.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 64.16B | 270.94% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 148.65B |
| Procter & Gamble Health | 97.22B |
| Viyash Scientific | 96.88B |
| Sanofi India | 77.92B |
| FDC Limited | 63.26B |
| Morepen Laboratories | 56.25B |
| Evonile Pharma | 42.46B |
| Gufic Biosciences | 41.85B |